Abstract: Cancer cachexia is a complex, multifactorial syndrome characterized by severe muscle wasting, weight loss, and systemic inflammation, significantly affecting patient prognosis and quality of ...

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...

For many families, the most shocking part of a cancer journey is not the tumour itself, but the steady wasting that follows — loss of appetite, falling weight, thinning muscles, and the feeling that ...

With cachexia, the muscles in your body will waste away regardless of how much you eat. The condition causes severe weight loss. (Photo Credit: Dr P. Marazzi/Science Source) Cachexia (aka “wasting ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

Cancer ravages both body and mind. If you’ve ever lost loved ones to the disease, you might recognize the physical and emotional changes cancer patients often endure during their final months. They ...

CatalYm has announced promising new data on its lead drug candidate, visugromab, at the 17th International Conference on Sarcopenia, Cachexia & Wasting Disorders (SCWD). The data from the ongoing ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...

The prevalence of cancer cachexia varies among different cancer types, with pancreatic, hepatobiliary, and oesophagogastric cancer having notably high rates Assess the patient for cancer cachexia in ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer ...